SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ariella who wrote (1489)8/1/1999 9:53:00 PM
From: erin4   of 1491
 
Pharmos and Dexanabinol featured on the national CBS Evening news on 8/1/99. Pharmos was mentioned by name and Dr Haim Aviv was pictured and named. Dexanabinol said to have remarkable ability to prevent brain damage after severe head trauma. A Dr. Marshall from Univ. of San Diego Medical Center says that Dexanabinol shows the best results in brain trauma patients that he has seen in 20 yrs.
The report then said that it would be 2 1/2 yrs before the drug would be available to patients unless the FDA granted priorty review status. Go Pharmos and sooner then 2 1/2 yrs please!!!!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext